Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-11-09 Purchase | 2020-11-12 5:05 pm | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Innovation Officer | 125,000 | $2.53 | $316,250 | 254,704 (Direct) | View |
| 2019-11-15 Purchase | 2019-11-19 4:02 pm | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Innovation Officer | 125,000 | $1.82 | $227,500 | 125,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 7:14 pm | N/A 2034-01-31 | Absci Corp | ABSI | Busch Andreas Chief Innovation Officer | 432,750 | $0 | 607,750 (Direct) | View |
| 2023-10-12 Option Award | 2023-10-16 6:11 pm | N/A N/A | Absci Corp | ABSI | Busch Andreas Chief Innovation Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 5:41 pm | N/A 2033-02-28 | Absci Corp | ABSI | Busch Andreas Chief Innovation Officer | 550,000 | $0 | 550,000 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 8:31 pm | N/A 2032-10-02 | Absci Corp | ABSI | Busch Andreas Chief Innovation Officer | 2,000,009 | $0 | 2,000,009 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:52 pm | N/A 2032-06-07 | Absci Corp | ABSI | Busch Andreas Director | 4,783 | $0 | 4,783 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-21 6:00 pm | N/A 2032-03-16 | Absci Corp | ABSI | Busch Andreas Director | 45,180 | $0 | 45,180 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-24 11:48 am | N/A 2032-01-20 | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2021-12-09 Option Award | 2021-12-10 4:32 pm | N/A 2031-12-09 | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Scientific Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-11-04 Option Award | 2020-11-06 4:43 pm | N/A 2030-11-04 | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Innovation Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2019-11-22 Option Award | 2019-11-26 5:41 pm | N/A 2029-11-22 | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Innovation Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2019-04-29 Option Award | 2019-05-01 5:18 pm | N/A 2029-04-29 | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Innovation Officer | 300,000 | $0 | 300,000 (Direct) | View |